Blade Air Mobility's Q2 2025: Key Contradictions in Medical Growth, Passenger Divestiture, and Strategic Focus

Medical segment focus and growth, divestiture of Passenger Business and Strategic Focus, aircraft repositioning impact on medical revenue, capital allocation and M&A strategy, and Passenger segment strategy and growth outlook are the key contradictions discussed in Blade Air Mobility's latest 2025Q2 earnings call, impacting investor trust and stock price volatility.



Blade Passenger Business Sale to Joby Aviation:
- Blade Air Mobility announced the sale of its Blade Passenger business to Joby Aviation for up to $125 million.
- The sale is expected to be adjusted EBITDA and free cash flow neutral on a go-forward annualized basis, with approximately $7 million in estimated corporate cost efficiencies.
- The transaction is transformational, enabling Strata Critical Medical, the remaining medical division, to focus on growth and acquisition strategies.

Medical Segment Revenue Growth:
- Medical revenues rose 17.6% year-over-year to a record setting $45.1 million in Q2 2025.
- Growth was driven by new transplant center customers, third-party service providers, and product line extensions like TOPS organ placement service.
- The company anticipates mid-teens revenue growth in the second half of the year with improved owned fleet uptime and adjusted EBITDA margins.

Passenger Segment Profitability Improvement:
- Despite a decrease in short distance revenue, Passenger segment adjusted EBITDA tripled year-over-year from $0.8 million to $2.4 million.
- This was due to improved flight margins, lower segment adjusted SG&A, and operational efficiencies following the restructuring in Europe and exit from Canada.
- The Passenger segment is expected to be neutral to adjusted EBITDA and free cash flow on a go-forward basis post-sale.

Capital Allocation and M&A Opportunities:
- Blade Air Mobility anticipates having approximately $200 million of cash pro forma for the Passenger sale, potentially increasing to $35 million based on employee retention and financial metrics.
- The company sees opportunities for both organic growth through TOPS and other verticals, as well as inorganic growth through strategic M&A.
- The focus is on scaling the business and leveraging its strong balance sheet for quick and nimble M&A deals.